PlayGait: A Dynamic Exoskeleton

NCT ID: NCT05318690

Last Updated: 2023-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-11

Study Completion Date

2023-01-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PlayGait is an investigational dynamic energy storage and return (ESR) lower-limb exoskeleton for young children with cerebral palsy (CP), that stores energy while the child is in the stance phase of walking and returns that energy in terminal stance and early swing phase of walking. PlayGait assists with the passive dynamics of walking through an exotendon (comprised of a spring in series with a cable). The overall objective of this investigational device is to promote correct walking patterns that encourage proper bone alignment, muscle recruitment, and strengthening during walking practice in young children with CP. The study will evaluate children with CP's activity levels in the community with and without PlayGait. The study will consist of three lab visits and two, 7-day periods at home.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PlayGait (Exoskeleton)

Experimental lower-limb device.

Group Type EXPERIMENTAL

PlayGait

Intervention Type DEVICE

PlayGait is a dynamic energy storing and returning lower-limb exoskeleton.

Baseline

Baseline condition without using any prescribed lower-limb orthoses.

Group Type ACTIVE_COMPARATOR

Baseline

Intervention Type OTHER

Baseline condition with no prescribed or intervention lower-limb devices.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PlayGait

PlayGait is a dynamic energy storing and returning lower-limb exoskeleton.

Intervention Type DEVICE

Baseline

Baseline condition with no prescribed or intervention lower-limb devices.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 3 - 4 years (at time of informed consent)
* Hemiplegic cerebral palsy
* If child uses an ankle-foot orthosis (AFO), parent/caregiver is willing to have the child stop wearing their prescribed AFO during data collections (lab sessions and two 7-day periods at home)
* Ability to walk at least 10 meters without the use of assistive devices or AFOs
* Ability to walk at least 1 minute without the use of assistive devices or AFOs
* Stiff knee gait - less than normal knee flexion during swing phase
* Hip flexion passive range of motion contracture less than 20 degrees
* Gross Motor Function Classification System (GMFCS) Levels I-II
* Modified Ashworth Scale (MAS) \<=2 for the gastrocnemius soleus, rectus femoris, and hamstrings
* Family has resources to attend all study sessions (transportation, schedule)
* Ability to speak and understand in English

Exclusion Criteria

* Orthopedic surgery in the last year
* Foster children or wards of the state
* Use wheelchair or stroller mobility as their primary method of independent mobility
* Severe visual impairment such that the visual impairment itself functionally limits mobility
* Phenol or Botox injections to the legs in the last 3 months
* Uncontrolled seizure disorder, defined as any seizure in the last 3 months that influenced mobility skills and function (seizures which did not affect mobility are acceptable)
* Lower limb fracture in the last 3 months
* Planned surgery or changes to movement disorder medication during the study period
* Inability to understand directions sufficiently to complete the study assessments
* Cognitive, behavioral, or any other issues that may not allow for effective study participation
* Unwilling to complete the study protocol
Minimum Eligible Age

3 Years

Maximum Eligible Age

4 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Disability, Independent Living, and Rehabilitation Research

FED

Sponsor Role collaborator

Orthocare Innovations, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jessica Zistatsis, MSME

Role: PRINCIPAL_INVESTIGATOR

Orthocare Innovations

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Orthocare Innovations, LLC

Edmonds, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0047-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pediatric Neural Sleeve Validation
NCT05660096 WITHDRAWN NA
Evaluating Wearable Robotic Assistance on Gait
NCT04119063 COMPLETED EARLY_PHASE1
EXOPULSE Mollii Suit & Cerebral Palsy
NCT06266286 RECRUITING NA